Intensity-modulated radiation therapy: emerging cancer treatment technology

The use of intensity-modulated radiation therapy (IMRT) is rapidly advancing in the field of radiation oncology. Intensity-modulated radiation therapy allows for improved dose conformality, thereby affording the potential to decrease the spectrum of normal tissue toxicities associated with IMRT. Preliminary results with IMRT are quite promising; however, the clinical data is relatively immature and overall patient numbers remain small. High-quality IMRT requires intensive physics support and detailed knowledge of three-dimensional anatomy and patterns of tumour spread. This review focuses on basic principles, and highlights the clinical implementation of IMRT in head and neck and prostate cancer.

[1]  William R. Fair,et al.  DOSE ESCALATION WITH THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AFFECTS THE OUTCOME IN PROSTATE CANCER , 1998 .

[2]  T R Mackie,et al.  Quality assurance of a helical tomotherapy machine. , 2004, Physics in medicine and biology.

[3]  Rick Chappell,et al.  Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  Vincent Grégoire,et al.  Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery. , 2004, International journal of radiation oncology, biology, physics.

[5]  C Clifton Ling,et al.  High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. , 2002, International journal of radiation oncology, biology, physics.

[6]  R Mohan,et al.  Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. , 1996, International journal of radiation oncology, biology, physics.

[7]  Alexandra L Hanlon,et al.  Prostate cancer radiotherapy dose response: an update of the fox chase experience. , 2004, The Journal of urology.

[8]  W. Tomé,et al.  Variations in target delineation for head and neck IMRT: An international multi-institutional study , 2004 .

[9]  A. Markoe,et al.  Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. , 2000, International journal of radiation oncology, biology, physics.

[10]  W. Tomé,et al.  IMRT delivery verification using a spiral phantom. , 2003, Medical physics.

[11]  K. Ang,et al.  CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  A. Pollack,et al.  Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire. , 1998, Urology.

[13]  Daniel A Low,et al.  Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. , 2003, International journal of radiation oncology, biology, physics.

[14]  G. Field,et al.  Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer. , 2002, International journal of radiation oncology, biology, physics.

[15]  E. Hall,et al.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT. , 2003, International journal of radiation oncology, biology, physics.

[16]  Eli Glatstein,et al.  The return of the snake oil salesmen. , 2003, International journal of radiation oncology, biology, physics.

[17]  E. B. Butler,et al.  Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. , 1999, International journal of radiation oncology, biology, physics.

[18]  M K Martel,et al.  Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. , 2000, International journal of radiation oncology, biology, physics.

[19]  Prakash Chinnaiyan,et al.  The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy. , 2005, International journal of radiation oncology, biology, physics.

[20]  George Starkschall,et al.  Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. , 2002, International journal of radiation oncology, biology, physics.

[21]  David J Brenner,et al.  What hypofractionated protocols should be tested for prostate cancer? , 2002, International journal of radiation oncology, biology, physics.

[22]  G J Kutcher,et al.  Three-dimensional conformal radiotherapy and dose escalation: where do we stand? , 1998, Seminars in radiation oncology.

[23]  T. Mackie,et al.  Tomotherapy. , 2020, Seminars in radiation oncology.

[24]  P. Xia,et al.  Intensity modulated radiation therapy for carcinoma of the nasopharynx: An update of the UCSF experience , 2004 .

[25]  R. Mohan,et al.  Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer. , 2004, International journal of radiation oncology, biology, physics.

[26]  T E Schultheiss,et al.  A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. , 1999, International journal of radiation oncology, biology, physics.

[27]  T R Mackie,et al.  Design of adaptive treatment margins for non-negligible measurement uncertainty: application to ultrasound-guided prostate radiation therapy. , 2004, Physics in medicine and biology.

[28]  Rick Chappell,et al.  Is α/β for prostate tumors really low? , 2001 .

[29]  P. Harari,et al.  Improving dose homogeneity in routine head and neck radiotherapy with custom 3-D compensation. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  Wolfgang A Tomé,et al.  The impact of daily shifts on prostate IMRT dose distributions. , 2004, Medical physics.

[31]  L. Dawson,et al.  Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.

[32]  E. Halperin.  Overpriced technology in radiation oncology. , 2000, International journal of radiation oncology, biology, physics.

[33]  Michael J. Zelefsky,et al.  High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. , 2002, International journal of radiation oncology, biology, physics.

[34]  B. Vikram,et al.  Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets. , 2002, Seminars in radiation oncology.

[35]  R K Ten Haken,et al.  Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. , 1999, International journal of radiation oncology, biology, physics.

[36]  C. Terhaard,et al.  Level II lymph nodes and radiation-induced xerostomia. , 2004, International journal of radiation oncology, biology, physics.

[37]  C. Langer,et al.  Concurrent chemoradiation using paclitaxel and carboplatin in locally advanced non-small cell lung cancer. , 1999, Seminars in radiation oncology.

[38]  L. Dawson,et al.  Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. , 2004, International journal of radiation oncology, biology, physics.

[39]  P. Xia,et al.  Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. , 2001, International journal of radiation oncology, biology, physics.

[40]  J. Deasy,et al.  A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. , 2001, International journal of radiation oncology, biology, physics.

[41]  J. Manola,et al.  A practical method to achieve prostate gland immobilization and target verification for daily treatment. , 2001, International journal of radiation oncology, biology, physics.

[42]  Jan J W Lagendijk,et al.  Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[43]  J. Fowler,et al.  Is alpha/beta for prostate tumors really low? , 2001, International journal of radiation oncology, biology, physics.

[44]  B. Emami,et al.  Parotid‐Sparing Irradiation for Cancer of the Oral Cavity: Maintenance of Oral Nutrition and Body Weight by Preserving Parotid Function , 2001, American journal of clinical oncology.

[45]  T E Schultheiss,et al.  Ultrasound-based stereotactic guidance in prostate cancer--quantification of organ motion and set-up errors in external beam radiation therapy. , 2000, Computer aided surgery : official journal of the International Society for Computer Aided Surgery.

[46]  R. Pötter,et al.  The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. , 2002, International journal of radiation oncology, biology, physics.

[47]  Patrick A Kupelian,et al.  Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. , 2002, International journal of radiation oncology, biology, physics.

[48]  John C Roeske,et al.  A survey of intensity‐modulated radiation therapy use in the United States , 2003, Cancer.

[49]  Joseph O Deasy,et al.  Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. , 2004, International journal of radiation oncology, biology, physics.

[50]  J. Fowler,et al.  Image guidance for precise conformal radiotherapy. , 2003, International journal of radiation oncology, biology, physics.

[51]  C. Ling,et al.  Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. , 1999, International journal of radiation oncology, biology, physics.